ASX rules gives them the Choice of not disclosing a non binding offer as long as it remains confidential but of course they Can and they should if it helps put Dimerix on the radar, that's my feel.
But happy to see we have something in writing even thought it's non binding which is completely normal as potential partners need to be a whole lot of due diligence.
- Forums
- ASX - By Stock
- DXB
- Ann: FSGS Study, Partnering & Commercialisation Investor Briefing
Ann: FSGS Study, Partnering & Commercialisation Investor Briefing, page-4
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.0¢ |
Change
-0.005(1.33%) |
Mkt cap ! $211.9M |
Open | High | Low | Value | Volume |
38.0¢ | 38.5¢ | 36.5¢ | $363.9K | 967.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 108801 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 104387 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 33862 | 0.370 |
9 | 108801 | 0.365 |
12 | 233200 | 0.360 |
4 | 73571 | 0.355 |
9 | 174873 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 102735 | 7 |
0.380 | 150516 | 6 |
0.385 | 23000 | 1 |
0.390 | 17637 | 3 |
0.395 | 142800 | 4 |
Last trade - 13.39pm 15/11/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online